CASEY TUREK: Open Payments
NPI 1003480534 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,015 in 193 payments from 23 companies in 2025. Trend: 2023 $2,089 · 2024 $2,770 · 2025 $5,015
Food & beverage: $4,915Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $570 |
| Incyte Corporation | 19 | $534 |
| Arcutis Biotherapeutics, Inc. | 27 | $476 |
| Amgen Inc. | 12 | $371 |
| Novartis Pharmaceuticals Corporation | 5 | $312 |
| Galderma Laboratories, L.P. | 10 | $282 |
| Regeneron Healthcare Solutions, Inc. | 12 | $269 |
| UCB, Inc. | 8 | $259 |
| GENZYME CORPORATION | 8 | $241 |
| Botanix SB Inc | 11 | $229 |
Products named: DUPIXENT, Opzelura, Zoryve, SKYRIZI, OTEZLA, Bimzelx, NEMLUVIO, SOFDRA.
Industry payments across FL — which companies pay providers there.
